NeoKare MMF is a powdered human milk derived product that may be recommended by healthcare professionals in the hospital. It has added Calcium and Phosphorus

NeoKare MMF can be used instead of the typical bovine-derived fortifier to increase the protein content of mother’s own or donor milk

Global and a growing body of evidence suggests that the an exclusive human milk diet (Human milk + human milk-derived fortifier) as opposed to using a bovine fortifier

  • It reduces the probability of NEC (necrotising enterocolitis) and Sepsis
  • Decreases the no of days of stay in hospital
  • Prevents long term health issues of obesity, allergy and diabetes which are associated with bovine based products.

All NeoKare products have been certified by the Vegan Society.

NeoKare 70Cal is a ready-to-drink liquid available as a frozen product. It has been standardised to have a minimum of 70Cal and 1.0g of protein per 100mL.

NeoKare’s products are available for direct in-hospital usage – please contact us at enquiry@neokare.co.uk for someone from the Commercial team to get in touch with you

The nutritional composition of breastmilk varies depending on individual characteristics and the lactation cycle stage.

NeoKare pool milk from several donors to ensure the maximum amount of protective factors are in each batch. After pooling, each batch is tested to ensure that it is within the nutritional recommendations. Thus, NeoKare can provide a standardised product that will help support each baby.

In a recent paper published in 2019 by British Journal of Nutrition, the authors have confirmed that human milk can have significant variability. Mean protein, fat, carbohydrate and calculated energy were 0·89 (SD 0·24) g/dl, 2·99 (SD 0·96) g/dl, 7·09 (SD 0·44) g/dl, and 60·37 (SD 8·41) kcal/dl, 252·59 (SD 35·19) kJ/dl). 1

Milks from randomly selected mothers contain as few as 23 and as many as 130 different oligosaccharides while 200 unique human milk oligosaccharides (HMO) structures varying from 3 to 22 sugars have been identified in mothers milk. By pooling, we are able to provide greater diversity of HMO’s to fragile infants. Our patented process is unique in retaining a large portion of micronutrients including HMO’s. 2

Pools with only one donor had lower total IgA and lower insulin concentrations than pools with at least 2 donors (p < 0.05). Increasing the number of donors in a pool decreased the variability in total IgA and insulin concentrations (p < 0.04). Conclusion: Increasing the number of donors included in DHM pools may help optimize bioactive components in DHM received by premature infants. 3

NeoKare’s products are the only human milk based products that are approved by the Vegan Society.

  • Mills L, Coulter L, Savage E, Modi N. Macronutrient content of donor milk from a regional human milk bank: variation with donor mother-infant characteristics. Br J Nutr. 2019 Nov 28;122(10):1155-1167.
  • Human Milk Oligosaccharides: Evolution, Structures and Bioselectivity as Substrates for Intestinal Bacteria J. Bruce German, Samara L. Freeman, Carlito B. Lebrilla, David A. Mills Department of Nutrition, University of California, Davis, CA, USA
  • Young BE, Murphy K, Borman LL, Heinrich R and Krebs NF (2020) Milk Bank Pooling Practices Impact Concentrations and Variability of Bioactive Components of Donor Human Milk. Front. Nutr. 7:579115. doi: 10.3389/fnut.2020.579115

NeoKare products are 100% breastmilk. This means that we receive milk, test it and pasteurise it. There are no additives.

The only exception is NeoKare MMF. NeoKare MMF contains additional phosphorus and calcium to support bone health in premature infants. This does not have a negative effect on the existing components of the breastmilk.

Cows Milk Protein Allergy (CMPA) affects between 1.8-7.5% of infants, and many more infants have intolerances to cow’s milk. Breast milk has protective factors against the development of allergies, and the prevalence of CMPA in breastfed babies is only 0.5%.

Many babies that don’t tolerate cow’s milk products are more accepting of human milk products. If you think your baby might be intolerant to cow’s milk products, you should get advice from your healthcare provider about which products will be suitable.

NeoKare provides a human-milk based alternative to cow’s milk formula’s. Cow’s milk proteins (casein and B-lactoglobulin) aren’t present in detectable amounts in the NeoKare range. However, if your child has proven cow’s milk allergy, you should always consult a healthcare professional before changing their diet.

NeoKare has a rigorous screening process for milk providers, including blood tests and a detailed screening questionnaire to ensure only safe milk is donated. Our onboarding process meets the requirements of the NICE CG93 guidelines.

At our pharmaceutical grade processing facility, milk is processed in ISO-7 cleanrooms to avoid contamination, and the final product is tested for both microbial and chemical parameters before being made available.

Although this is an ongoing area of study, it has been deemed highly unlikely that Covid-19 will be passed on to infants through breast milk. The highest risk is the close contact that comes with breastfeeding rather than the milk itself.

Furthermore, NeoKare pasteurises milk (this is a gentle heating process), pasteurisation is known to destroy several harmful diseases, viruses and other pathogens that may be present in milk.

Although data is still being collected, the current guidance still supports the use of donor milk products during Covid-19.